Liquidia (LQDA) Net Income (QoQ) (2020 - 2026)
Powered by 
Analysis
Liquidia (LQDA) Net Income (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Liquidia | 6.11 Bn | 5.82 Bn | 160.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.31% |
| Mar 31, 2026 | 263.19% |
| Dec 31, 2025 | 511.97% |
| Sep 30, 2025 | 91.50% |
| Jun 30, 2025 | -8.37% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | -24.11% |
| Sep 30, 2024 | -8.24% |
| Jun 30, 2024 | 4.70% |
| Mar 31, 2024 | -9.59% |
| Dec 31, 2023 | -73.84% |
| Sep 30, 2023 | 32.86% |
| Jun 30, 2023 | -149.28% |
| Mar 31, 2023 | -44.41% |
| Dec 31, 2022 | 28.15% |
| Sep 30, 2022 | 3.76% |
| Jun 30, 2022 | 36.79% |
| Mar 31, 2022 | -29.26% |
| Dec 31, 2021 | -58.81% |
| Sep 30, 2021 | -11.13% |